E-Mail
IMAGE: This schematic shows some of the location where SARS-CoV-2 s genetic signature was detected in the intensive care unit (ICU) and other hospital rooms. view more
Credit: UC San Diego Health Sciences
Watching what was happening around the world in early 2020, University of California San Diego School of Medicine researchers knew their region would likely soon be hit with a wave of patients with COVID-19, the infection caused by the coronavirus SARS-CoV-2. They wondered how the virus persists on surfaces, particularly in hospitals, and they knew they had only a small window of time to get started if they wanted to capture a snapshot of the before situation before patients with the infection were admitted.
Following the Food and Drug Administration's approval, UC San Diego Health is the first designated medical center in San Diego certified to offer a new immunotherapy treatment of multiple myeloma outside of a clinical trial.
For 17 harrowing days in November 2018, the deadliest wildfire in the California’s history swept across the northern region of the state. Officially dubbed the Camp Fire (named after its origin point at Camp Creek Road in Butte County), the fire continued to spread for several weeks, capturing national attention. Scientists and environmental experts recognized it as a sign of the increasing impacts of climate change on the West Coast wildfire season: As global temperatures rise, California’s already fire-prone landscape becomes more susceptible to dangerous blazes with each passing year.
For locals, the Camp Fire’s effects have long outlasted that initial media frenzy. Three years later, and many Californians are still working to rebuild their homes and lives. But disasters like this permeate deeper than the immediate economic damage they also have a long-term impact on human health. A new study in
Social Justice as Part of the Remedy for What Ails Us New center in Sanford Institute for Empathy and Compassion focuses on issues in health care June 03, 2021 | Scott LaFee; Mario Aguilera
News release
Eliminating racial inequity demands empathy and compassion, but also social justice.
The newest center within the T. Denny Sanford Institute for Empathy and Compassion at UC San Diego will have that focus, created to identify, understand and resolve social justice issues in health care that primarily affect racial and ethnic minorities, women, LGBTQ and under-privileged communities.
“Across this country and throughout society, we face extraordinary challenges regarding racial injustice, especially those impacting marginalized members of our communities,” said Gentry Patrick, PhD, a professor of neurobiology in the Division of Biological Sciences and the newly named director of the Center for Empathy and Social Justice in Human Health within the Sanford In
E-Mail
Following the Food and Drug Administration s approval, UC San Diego Health is the first designated medical center in San Diego certified to offer a new immunotherapy treatment of multiple myeloma outside of a clinical trial.
The new immunotherapy is a B-cell maturation antigen (BCMA) directed chimeric antigen receptor (CAR) T-cell therapy, and UC San Diego Health is preparing to treat its first patient this month.
Multiple myeloma is a cancer of blood plasma cells in which the body s T-cells and B-cells become cancerous and multiply. According to the National Cancer Institute, nearly 35,000 Americans will be diagnosed with multiple myeloma in 2021, and treatment options are limited.